These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9425802)
1. Epidemiology of onychomycosis in special-risk populations. Levy LA J Am Podiatr Med Assoc; 1997 Dec; 87(12):546-50. PubMed ID: 9425802 [TBL] [Abstract][Full Text] [Related]
2. The prevalence and management of onychomycosis in diabetic patients. Gupta AK; Humke S Eur J Dermatol; 2000; 10(5):379-84. PubMed ID: 10882947 [TBL] [Abstract][Full Text] [Related]
3. Increased prevalence of onychomycosis among psoriatic patients in Israel. Leibovici V; Hershko K; Ingber A; Westerman M; Leviatan-Strauss N; Hochberg M Acta Derm Venereol; 2008; 88(1):31-3. PubMed ID: 18176747 [TBL] [Abstract][Full Text] [Related]
4. Are local and systemic conditions important for the development of onychomycosis? Tosti A; Piraccini BM; Mariani R; Stinchi C; Buttasi C Eur J Dermatol; 1998; 8(1):41-4. PubMed ID: 9649691 [TBL] [Abstract][Full Text] [Related]
5. Fungal nail infections: far more than an aesthetic problem. Bending A Br J Community Nurs; 2002 May; 7(5):254-9. PubMed ID: 12048499 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations. Gupta AK; Daigle D; Foley KA J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1039-44. PubMed ID: 25413984 [TBL] [Abstract][Full Text] [Related]
7. The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001. Ioannidou DJ; Maraki S; Krasagakis SK; Tosca A; Tselentis Y J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):170-4. PubMed ID: 16441625 [TBL] [Abstract][Full Text] [Related]
9. Do fungi play a role in psoriatic nails? Szepietowski JC; Salomon J Mycoses; 2007 Nov; 50(6):437-42. PubMed ID: 17944702 [TBL] [Abstract][Full Text] [Related]
10. Toenail onychomycosis: an important global disease burden. Thomas J; Jacobson GA; Narkowicz CK; Peterson GM; Burnet H; Sharpe C J Clin Pharm Ther; 2010 Oct; 35(5):497-519. PubMed ID: 20831675 [TBL] [Abstract][Full Text] [Related]
11. HIV Infection Manifesting as Proximal White Onychomycosis. Gómez-Moyano E; Crespo-Erchiga V N Engl J Med; 2017 Nov; 377(18):e26. PubMed ID: 29091566 [No Abstract] [Full Text] [Related]
12. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections. Cribier BJ; Bakshi R Br J Dermatol; 2004 Mar; 150(3):414-20. PubMed ID: 15030322 [TBL] [Abstract][Full Text] [Related]
13. [Onychomycosis frequency in psoriatic patients in a tertiary care hospital]. Méndez-Tovar LJ; Arévalo-López A; Domínguez-Aguilar S; Manzano-Gayosso P; Hernández-Hernández F; López Martínez R; Silva González I Rev Med Inst Mex Seguro Soc; 2015; 53(3):374-9. PubMed ID: 25984624 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Gupta AK; Taborda P; Taborda V; Gilmour J; Rachlis A; Salit I; Gupta MA; MacDonald P; Cooper EA; Summerbell RC Int J Dermatol; 2000 Oct; 39(10):746-53. PubMed ID: 11095193 [TBL] [Abstract][Full Text] [Related]